Nuclear Medicine & Molecular Oncologic Imaging - Q: What are the differences in patient preparation for 18 F-FDG PET-CT and 18-F Fluciclovine (Axumin) study? ⠀⠀⠀⠀⠀⠀⠀⠀⠀ Answer: 1. Both studies require at least
![Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary](https://www.spandidos-publications.com/article_images/ol/12/5/ol-12-05-3785-g00.jpg)
Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary
![The Use of F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases The Use of F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases](https://static.hindawi.com/articles/jir/volume-2013/623036/figures/623036.fig.001a.jpg)
The Use of F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
![Disseminated focal 18F-fluoro-deoxyglucose uptake upon granulocyte colony-stimulating factor therapy mimicking malignant bone infiltration: case report of a patient with very severe aplastic anemia - Lena Horvath, Andreas Seeber, Christian Uprimny ... Disseminated focal 18F-fluoro-deoxyglucose uptake upon granulocyte colony-stimulating factor therapy mimicking malignant bone infiltration: case report of a patient with very severe aplastic anemia - Lena Horvath, Andreas Seeber, Christian Uprimny ...](https://journals.sagepub.com/cms/10.1177/2040620720977613/asset/images/large/10.1177_2040620720977613-fig1.jpeg)
Disseminated focal 18F-fluoro-deoxyglucose uptake upon granulocyte colony-stimulating factor therapy mimicking malignant bone infiltration: case report of a patient with very severe aplastic anemia - Lena Horvath, Andreas Seeber, Christian Uprimny ...
![Frontiers | 18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer's Disease Frontiers | 18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer's Disease](https://www.frontiersin.org/files/Articles/428559/fnagi-10-00425-HTML-r1/image_m/fnagi-10-00425-g001.jpg)
Frontiers | 18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer's Disease
![The Diagnostic Contribution of (18)F-FDG PET/CT Scan in Cancer of Unknown Primary | Semantic Scholar The Diagnostic Contribution of (18)F-FDG PET/CT Scan in Cancer of Unknown Primary | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4402dc835a6ffee44fee32544077c3a26fc37ed9/4-Figure1-1.png)
The Diagnostic Contribution of (18)F-FDG PET/CT Scan in Cancer of Unknown Primary | Semantic Scholar
![A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis | Scientific Reports A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-13345-4/MediaObjects/41598_2022_13345_Fig1_HTML.png)
A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis | Scientific Reports
![PET/CT detection of Fludeoxyglucose F 18 Injection (18F FDG)-avid, radioiodine negative recurrent thyroid cancer - Siemens Healthineers Nederland PET/CT detection of Fludeoxyglucose F 18 Injection (18F FDG)-avid, radioiodine negative recurrent thyroid cancer - Siemens Healthineers Nederland](https://marketing.webassets.siemens-healthineers.com/1800000005356172/48a45353d3e3/v/e76a3247d30f/PETCT_Detection_of_18F_FDG-avid_1800000005356172.jpg)
PET/CT detection of Fludeoxyglucose F 18 Injection (18F FDG)-avid, radioiodine negative recurrent thyroid cancer - Siemens Healthineers Nederland
![Pharmaceuticals | Free Full-Text | Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer Pharmaceuticals | Free Full-Text | Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00521/article_deploy/html/images/pharmaceuticals-16-00521-g001.png)
Pharmaceuticals | Free Full-Text | Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer
![Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study | Journal of Nuclear Medicine Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/8/1155/F1.large.jpg)
Head-to-Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for Evaluation of Head and Neck Squamous Cell Carcinoma: A Single-Center Exploratory Study | Journal of Nuclear Medicine
![Head-to-head Intra-individual Comparison of [ 68 Ga]-FAPI and [ 18 F]-FDG PET/CT in Patients with Bladder Cancer - SOFIE Head-to-head Intra-individual Comparison of [ 68 Ga]-FAPI and [ 18 F]-FDG PET/CT in Patients with Bladder Cancer - SOFIE](https://sofie.com/wp-content/uploads/2022/06/Head-to-head-Intra-individual-Comparison.png)
Head-to-head Intra-individual Comparison of [ 68 Ga]-FAPI and [ 18 F]-FDG PET/CT in Patients with Bladder Cancer - SOFIE
![Figure 3: Diffuse Spondylodiscitis Revealed By 18F-FDG-PET/CT Scanning in an Asymptomatic Patient With Lead Endocarditis | Radcliffe Cardiology Figure 3: Diffuse Spondylodiscitis Revealed By 18F-FDG-PET/CT Scanning in an Asymptomatic Patient With Lead Endocarditis | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/Figure-3-Diffuse-Spondylodiscitis-Revealed-By-18F-FDG-PET-CT.png)